Compile Data Set for Download or QSAR
maximum 50k data
Found 96 Enz. Inhib. hit(s) with Target = 'Solute carrier family 2, facilitated glucose transporter member 3'
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152749(CHEMBL3781913)
Affinity DataIC50:  8nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155671(CHEMBL3780239)
Affinity DataIC50:  10nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453246(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  12nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  26nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  33nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155656(CHEMBL3781331)
Affinity DataIC50:  37nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155673(CHEMBL3780972)
Affinity DataIC50:  40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152824(CHEMBL3781548)
Affinity DataIC50:  40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155746(CHEMBL3781151)
Affinity DataIC50:  46nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453228(US10729691, Example 13)
Affinity DataIC50:  47nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155670(CHEMBL3780144)
Affinity DataIC50:  50nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538375(CHEMBL4633651)
Affinity DataIC50:  58nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155715(CHEMBL3781149)
Affinity DataIC50:  60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155585(CHEMBL3780372)
Affinity DataIC50:  60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152776(CHEMBL3780785)
Affinity DataIC50:  64nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453227(US10729691, Example 12)
Affinity DataIC50:  68nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155680(CHEMBL3780717)
Affinity DataIC50:  69nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155583(CHEMBL3781835)
Affinity DataIC50:  70nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155751(CHEMBL3780460)
Affinity DataIC50:  90nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155745(CHEMBL3780043)
Affinity DataIC50:  96nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453217(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  97nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152825(CHEMBL3780235)
Affinity DataIC50:  110nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152827(CHEMBL3781741)
Affinity DataIC50:  120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155752(CHEMBL3780527)
Affinity DataIC50:  120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152743(CHEMBL3781308)
Affinity DataIC50:  120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538374(CHEMBL4637134)
Affinity DataIC50:  121nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538373(CHEMBL4635564)
Affinity DataIC50:  138nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538389(CHEMBL4634012)
Affinity DataIC50:  155nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453248(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  160nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155672(CHEMBL3781183)
Affinity DataIC50:  170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155679(CHEMBL3780772)
Affinity DataIC50:  170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155749(CHEMBL3781625)
Affinity DataIC50:  170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538390(CHEMBL4638542)
Affinity DataIC50:  175nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538386(CHEMBL4647401)
Affinity DataIC50:  179nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155747(CHEMBL3781194)
Affinity DataIC50:  200nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538383(CHEMBL4645036)
Affinity DataIC50:  211nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538382(CHEMBL4649311)
Affinity DataIC50:  232nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM453219(US10729691, Example 4)
Affinity DataIC50:  238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538387(CHEMBL4642809)
Affinity DataIC50:  238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155714(CHEMBL3781157)
Affinity DataIC50:  250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50152826(CHEMBL3781347)
Affinity DataIC50:  250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538391(CHEMBL4642046)
Affinity DataIC50:  275nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538385(CHEMBL4632395)
Affinity DataIC50:  287nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538365(CHEMBL4632920)
Affinity DataIC50:  298nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155753(CHEMBL3780470)
Affinity DataIC50:  320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155681(CHEMBL3781827)
Affinity DataIC50:  320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538368(CHEMBL4649877)
Affinity DataIC50:  325nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155750(CHEMBL3780595)
Affinity DataIC50:  340nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50155677(CHEMBL3780765)
Affinity DataIC50:  350nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50538372(CHEMBL4637262)
Affinity DataIC50:  365nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: